Gadolinium enhancement of cerebrospinal fluid in a patient with renal failure

Neuroradiology

Volumn 43, Issue 11, 2001, Pages 1001-1004

  Erbay, S H ^a   Bhadelia, R A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebrospinal fluid; Contrast agents; Gadolinium

Indexed keywords

GADOLINIUM; GADOTERIDOL;

AGED; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CONTRAST ENHANCEMENT; DISEASE SEVERITY; DRUG ELIMINATION; DRUG SAFETY; FEMALE; HUMAN; KIDNEY FAILURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TOXIC MEGACOLON;

AGED; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING;

EID: 0035177959     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002340100606     Document Type: Article

References (11)

1. Visualization of intravenously administered contrast material in the CSF on FLAIR MR images: An in vitro and animal model investigation
2. Gd-DTPA enhancement of CSF in meningeal carcinomatosis
3. Gadolinium enhancement of the CSF in a patient with meningeal fibrosis and cryptococcal infection
4. Extensive cerebrospinal fluid enhancement with gadopentetate dimeglumine in a primitive neuroectodermal tumor
5. Systemic gadolinium toxicity in renal insufficiency and renal failure: Retrospective analysis of an initial experience
6. Magnetic resonance contrast agents for neuroimaging. Safety issues
7. Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure
8. Measurement of blood-brain barrier permeability using dynamic Gd-DTPA scanning - A comparison method
9. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1 Fundamental concepts
10. The effect of intravenous gadolinium on the magnetic resonance appearance of cerebrospinal fluid
11. Brain penetration and neurological effect of gadobenate dimeglumine in the rat